Selected research
Industry Research
Biomolecular Design Platform Industry Research Report 2026
Market perspective
The global Biomolecular Design Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biomolecular Design Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biomolecular Design Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biomolecular Design Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biomolecular Design Platform include Schrödinger, Absci, Recursion, Exscientia, Insilico Medicine, Relay Therapeutics, Atomwise, Cradle and Iambic Therapeutics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biomolecular Design Platform market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biomolecular Design Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biomolecular Design Platform Market by Company
Schrödinger
Absci
Recursion
Exscientia
Insilico Medicine
Relay Therapeutics
Atomwise
Cradle
Iambic Therapeutics
Etcembly
Distributed Bio
BigHat Biosciences
Ginkgo Bioworks
Arzeda
LabGenius
Biomolecular Design Platform Segment by Type
Computational Simulation Platform
AI-Driven Platform
Hybrid-Driven Platform
Others
Biomolecular Design Platform Segment by Application
Agriculture and Food Technology Industry
Cosmetics and Personal Care Industry
Environment and Energy Industry
Others
Biomolecular Design Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomolecular Design Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomolecular Design Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomolecular Design Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biomolecular Design Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Computational Simulation Platform
- AI-Driven Platform
- Hybrid-Driven Platform
- Others
Applications
- Agriculture and Food Technology Industry
- Cosmetics and Personal Care Industry
- Environment and Energy Industry
- Others
Companies covered
- Schrödinger
- Absci
- Recursion
- Exscientia
- Insilico Medicine
- Relay Therapeutics
- Atomwise
- Cradle
- Iambic Therapeutics
- Etcembly
- Distributed Bio
- BigHat Biosciences
- Ginkgo Bioworks
- Arzeda
- LabGenius
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biomolecular Design Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Computational Simulation Platform
- 2.2.3 AI-Driven Platform
- 2.2.4 Hybrid-Driven Platform
- 2.2.5 Others
- 2.3 Biomolecular Design Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Agriculture and Food Technology Industry
- 2.3.3 Cosmetics and Personal Care Industry
- 2.3.4 Environment and Energy Industry
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Biomolecular Design Platform Breakdown Data by Type
- 3.1 Global Biomolecular Design Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Biomolecular Design Platform Forecasted Market Size by Type (2027-2032)
4 Biomolecular Design Platform Breakdown Data by Application
- 4.1 Global Biomolecular Design Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Biomolecular Design Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biomolecular Design Platform Market Perspective (2021-2032)
- 5.2 Global Biomolecular Design Platform Growth Trends by Region
- 5.2.1 Global Biomolecular Design Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biomolecular Design Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Biomolecular Design Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Biomolecular Design Platform Market Dynamics
- 5.3.1 Biomolecular Design Platform Industry Trends
- 5.3.2 Biomolecular Design Platform Market Drivers
- 5.3.3 Biomolecular Design Platform Market Challenges
- 5.3.4 Biomolecular Design Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biomolecular Design Platform Players by Revenue
- 6.1.1 Global Top Biomolecular Design Platform Players by Revenue (2021-2026)
- 6.1.2 Global Biomolecular Design Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Biomolecular Design Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biomolecular Design Platform Head Office and Area Served
- 6.4 Global Biomolecular Design Platform Players, Product Type & Application
- 6.5 Global Biomolecular Design Platform Manufacturers Established Date
- 6.6 Global Biomolecular Design Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biomolecular Design Platform Market Size (2021-2032)
- 7.2 North America Biomolecular Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biomolecular Design Platform Market Size by Country (2021-2026)
- 7.4 North America Biomolecular Design Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biomolecular Design Platform Market Size (2021-2032)
- 8.2 Europe Biomolecular Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biomolecular Design Platform Market Size by Country (2021-2026)
- 8.4 Europe Biomolecular Design Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biomolecular Design Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Biomolecular Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biomolecular Design Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biomolecular Design Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biomolecular Design Platform Market Size (2021-2032)
- 10.2 South America Biomolecular Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biomolecular Design Platform Market Size by Country (2021-2026)
- 10.4 South America Biomolecular Design Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biomolecular Design Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Biomolecular Design Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biomolecular Design Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biomolecular Design Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Schrödinger
- 12.1.1 Schrödinger Company Information
- 12.1.2 Schrödinger Business Overview
- 12.1.3 Schrödinger Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.1.4 Schrödinger Biomolecular Design Platform Product Portfolio
- 12.1.5 Schrödinger Recent Developments
- 12.2 Absci
- 12.2.1 Absci Company Information
- 12.2.2 Absci Business Overview
- 12.2.3 Absci Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.2.4 Absci Biomolecular Design Platform Product Portfolio
- 12.2.5 Absci Recent Developments
- 12.3 Recursion
- 12.3.1 Recursion Company Information
- 12.3.2 Recursion Business Overview
- 12.3.3 Recursion Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.3.4 Recursion Biomolecular Design Platform Product Portfolio
- 12.3.5 Recursion Recent Developments
- 12.4 Exscientia
- 12.4.1 Exscientia Company Information
- 12.4.2 Exscientia Business Overview
- 12.4.3 Exscientia Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.4.4 Exscientia Biomolecular Design Platform Product Portfolio
- 12.4.5 Exscientia Recent Developments
- 12.5 Insilico Medicine
- 12.5.1 Insilico Medicine Company Information
- 12.5.2 Insilico Medicine Business Overview
- 12.5.3 Insilico Medicine Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.5.4 Insilico Medicine Biomolecular Design Platform Product Portfolio
- 12.5.5 Insilico Medicine Recent Developments
- 12.6 Relay Therapeutics
- 12.6.1 Relay Therapeutics Company Information
- 12.6.2 Relay Therapeutics Business Overview
- 12.6.3 Relay Therapeutics Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.6.4 Relay Therapeutics Biomolecular Design Platform Product Portfolio
- 12.6.5 Relay Therapeutics Recent Developments
- 12.7 Atomwise
- 12.7.1 Atomwise Company Information
- 12.7.2 Atomwise Business Overview
- 12.7.3 Atomwise Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.7.4 Atomwise Biomolecular Design Platform Product Portfolio
- 12.7.5 Atomwise Recent Developments
- 12.8 Cradle
- 12.8.1 Cradle Company Information
- 12.8.2 Cradle Business Overview
- 12.8.3 Cradle Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.8.4 Cradle Biomolecular Design Platform Product Portfolio
- 12.8.5 Cradle Recent Developments
- 12.9 Iambic Therapeutics
- 12.9.1 Iambic Therapeutics Company Information
- 12.9.2 Iambic Therapeutics Business Overview
- 12.9.3 Iambic Therapeutics Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.9.4 Iambic Therapeutics Biomolecular Design Platform Product Portfolio
- 12.9.5 Iambic Therapeutics Recent Developments
- 12.10 Etcembly
- 12.10.1 Etcembly Company Information
- 12.10.2 Etcembly Business Overview
- 12.10.3 Etcembly Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.10.4 Etcembly Biomolecular Design Platform Product Portfolio
- 12.10.5 Etcembly Recent Developments
- 12.11 Distributed Bio
- 12.11.1 Distributed Bio Company Information
- 12.11.2 Distributed Bio Business Overview
- 12.11.3 Distributed Bio Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.11.4 Distributed Bio Biomolecular Design Platform Product Portfolio
- 12.11.5 Distributed Bio Recent Developments
- 12.12 BigHat Biosciences
- 12.12.1 BigHat Biosciences Company Information
- 12.12.2 BigHat Biosciences Business Overview
- 12.12.3 BigHat Biosciences Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.12.4 BigHat Biosciences Biomolecular Design Platform Product Portfolio
- 12.12.5 BigHat Biosciences Recent Developments
- 12.13 Ginkgo Bioworks
- 12.13.1 Ginkgo Bioworks Company Information
- 12.13.2 Ginkgo Bioworks Business Overview
- 12.13.3 Ginkgo Bioworks Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.13.4 Ginkgo Bioworks Biomolecular Design Platform Product Portfolio
- 12.13.5 Ginkgo Bioworks Recent Developments
- 12.14 Arzeda
- 12.14.1 Arzeda Company Information
- 12.14.2 Arzeda Business Overview
- 12.14.3 Arzeda Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.14.4 Arzeda Biomolecular Design Platform Product Portfolio
- 12.14.5 Arzeda Recent Developments
- 12.15 LabGenius
- 12.15.1 LabGenius Company Information
- 12.15.2 LabGenius Business Overview
- 12.15.3 LabGenius Revenue in Biomolecular Design Platform Business (2021-2026)
- 12.15.4 LabGenius Biomolecular Design Platform Product Portfolio
- 12.15.5 LabGenius Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst